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Abstract
Influenza A virus can infect a wide variety of animal species with illness ranging from mild to severe, and is a continual cause
for concern. Genetic mutations that occur either naturally or during viral adaptation in a poorly susceptible host are key
mechanisms underlying the evolution and virulence of influenza A virus. Here, the variants containing PA-A36T or PB2-
H357N observed in the mouse-adapted descendants of 2009 pandemic H1N1 virus (pH1N1), A/Sichuan/1/2009 (SC), were
characterized. Both mutations enhanced polymerase activity in mammalian cells. These effects were confirmed using
recombinant SC virus containing polymerase genes with wild type (WT) or mutant PA or PB2. The PA-A36T mutant showed
enhanced growth property compared to the WT in both human A549 cells and porcine PK15 cells in vitro, without
significant effect on viral propagation in murine LA-4 cells and pathogenicity in mice; however, it did enhance the lung virus
titer. PB2-H357N variant demonstrated growth ability comparable to the WT in A549 cells, but replicated well in PK15, LA-4
cells and in mice with an enhanced pathogenic phenotype. Despite such mutations are rare in nature, they could be
observed in avian H5 and H7 subtype viruses which were currently recognized to pose potential threat to human. Our
findings indicated that pH1N1 may adapt well in mammals when acquiring these mutations. Therefore, future molecular
epidemiological surveillance should include scrutiny of both markers because of their potential impact on pathogenesis.
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Introduction
Influenza A viruses are highly infectious to a variety of
mammalian and avian species. Individual viruses are host-specific;
however, interspecies transmission of influenza A viruses is not
uncommon. Many evidences suggested that genetic mutations in
viral proteins, including envelope hemagglutinin (HA) and
neuraminidase (NA) glycoproteins [1], nonstructural proteins
NS1 [2,3] and PB1-F2 [4], and the polymerase complex, occur
during viral host adaptation and result in enhanced virulence. Of
these identified gene markers, viral RNA-dependent RNA
polymerase (RdRp), comprising the PB2, PB1, and PA subunits,
performs important functions during flu pathogenesis. An avian-
like PB1 or its introduction into human-adapted influenza virus
might provide a replicative advantage to the new virus for
establishing infection in a new host specie, for example, the 1918,
1957 and 1968 pandemic influenza viruses [1,5–8]. Avian viruses
with lysine at position 627 in PB2 replicate efficiently in human
cells [9,10] and exhibit higher pathogenicity in mice [11–13].
Another amino acid substitution at position 701 in PB2 was
involved in the increased lethality of duck-origin H5N1 and avian
H7N7 viruses in a mouse model [14–16]. Furthermore, both of
these PB2 mutations contribute to the transmission of H5N1 virus
in guinea pigs [12,14,17–19]. A mutation close to the cap-binding
region of PB2, T271A, may also enhance viral polymerase activity
in mammalian cells [20]. Both PB2 and PB1 were found to be
responsible for the high virulence of human H5N1 virus in mice
and ferrets [21]. Additionally, recent findings suggested that the
PA gene of H5N1 viruses is involved in increased virulence to both
avian and mammalian hosts [22,23].
The 2009 pandemic influenza A (H1N1) virus is a swine-origin
reassortant with human, avian and swine influenza virus genes. In
particular, the polymerase contains PB2 and PA of avian origin,
PB1 derived from human viruses and NP from the classical swine
lineage. This novel virus was transmitted efficiently from human to
human and was more pathogenic than seasonal influenza viruses
in both the naive pediatric population and animal models [24–28].
However, point mutations of known molecular markers, such as
PB2 E627K / D701N/ E677G, PB1-F2 N66S, and PA T97I
[15,29–32], produced no significant change in pathogenicity when
incorporated in pH1N1 individually. Dual receptor-binding
preference, as well as the interaction of viral polymerase
components with cellular factors, was found to account for the
enhanced lethality of pH1N1 adapting in mice after serial lung-to-
lung passage [33,34]. The D222G substitution in pH1N1 HA,
occurring either naturally or as a mouse-adaptation, was
associated with severe or fatal disease in mice by altering cell
tropism [35,36]. PB2-590/591 (SR) polymorphism were found to
help pH1N1 overcome host restriction by enhancing viral
replication [15,37] and PB2-E158G was a determinant mutation
in the adaptation of avian PB2 genes of pH1N1 in mammals [30].
Synergistic effect of mutations in PA (F35L) and HA (D222G and
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[38]. Mutations in PA, HA and NP have been identified to be
related to viral adaptation of pH1N1 to a new host [39].
One or multiple mutations in HA (at position 155, 163, 222 or
223), NA (at position 63), and polymerase (at position 357 of PB2
or 36 of PA ) were found in our recent work on the adaptation of
pH1N1 virus, A/Sichuan/1/2009(SC) after 15 passage times in
mice [40]. The mutants with single polymerase mutation of PA-
A36T or PB2-H357N were found in mouse-adapted descendants
of SC. Of 5,875 PA and 5,633 PB2 sequences analyzed up to Jan
30
th 2012, less than 1% (including H5 and H7 subtypes) carried
these mutations in nature. However, little is known about the
impacts of these two rare mutations on virus properties. In this
study we fully characterized the variants containing substitution
PA-A36T or PB2-H357N in vitro and in vivo.
Materials and Methods
Cell culture
Human embryonic kidney (293T) cells, human type II alveolar
epithelial (A549) cell, Madin-Darby canine kidney (MDCK),
porcine kidney (PK15) and mouse lung adenoma (LA-4) cells were
obtained from the American Type Culture Collection. 293T and
A549 cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM; Invitrogen, Carlsbad, CA, USA) and MDCK
and PK15 were in minimum essential medium (MEM; Invitrogen,
Carlsbad, CA, USA), respectively, supplemented with 10% fetal
bovine serum (FBS; Invitrogen), glutamine (2 mM; Invitrogen),
HEPES (10 mM; Invitrogen), penicillin (100 units/ml), and
streptomycin (100 mg/ml; Invitrogen). LA-4 cells were propagated
in Ham’s F12K medium (Sigma, Saint Louis, MO, USA) with
2 mM L-glutamine and 15% FBS.
Site-Directed Mutagenesis
All eight gene segments of influenza virus A/Sichuan/1/2009
(H1N1, SC_WT) were amplified by RT-PCR and cloned into a
modified version of the bidirectional expression plasmid pCQI,
derived from pHW2K. Mutations(PA-A36T and PB2-H357N) were
introduced into the plasmids to generate mutant segments using a
QuikChange
TMSite-Directed MutagenesisKit (Stratagene, LaJolla,
CA, USA), following the manufacturer’s instructions. The presence
of the introduced mutation and the absence of additional unwanted
mutations were verified by sequencing of the whole cDNA.
Generation of recombinant viruses and virus titration
Recombinant viruses SC_WT and SC_PA-A36T/ SC_PB2-
H357N were generated by reverse-genetics method as described as
previously [41]. In general, eight plasmids containing the dsDNA
representing each gene segment were co-transfected into a 293T/
MDCK co-culture monolayer. The identity of propagated mutant
viruses was ascertained by sequencing amplicons of each viral gene
segment by RT-PCR. Viral titrations were determined using MDCK
cells, and the tissue culture infectious dose affecting 50% of the cells
(TCID50) was calculated using the Reed–Muench formula [42].
Mini-genome replication assay
polI-Gluc (0.1 mg) [43] were co-transfected with expression
plasmids encoding PB2, PB1, PA, and NP into 293T, A549 or
PK15 cells (3610
4 /well in 96-well plates) using the PolyFect
(Qiagen, Valencia, CA, USA) reagent, according to the manufac-
turer’s instructions. Mock transfections were performed with polI-
Gluc alone. Gluc activity in supernatants was analyzed using a
Gluc assay Kit (New England Biolabs, Beverly, MA, USA). Each
sample was determined in triplicates.
Growth Curves
A549, PK15 and LA-4 cells were infected with rescued viruses
at a multiplicity of infection (MOI) of 0.0001, and incubated in the
appropriate medium containing 2 mg/L N-p-tosyl-L-phenylalani-
nechloromethyl ketone-treated (TPCK) trypsin (Sigma, Saint
Louis, MO, USA) at 35 or 39uC. At 12, 24, 48, 60, 72, and
96 hour post-inoculation (hpi), supernatants were harvested and
virus titer was determined using MDCK cells as described [42].
Mouse studies
Our mice experiment protocol was approved by the Ethics
Committee of National Institute for Viral Disease Control and
Prevention, China CDC (IORG0000724). To determine the 50%
mouse lethal dose (MLD50), groups of five 6-week-old female
BALB/c mice obtained from Vital Reviver, PRC, were anesthe-
tized with isoflurane and intranasally inoculated with 50 ml of 10-
fold serial dilutions of viruses in phosphate-buffered saline (PBS).
The MLD50 values were calculated by the method of Reed-
Muench [42] after a 14-day observation period and expressed as
TCID50 causing half fatality. To determine morbidity and
mortality, we inoculated groups of 6-week-old female BALB/c
mice intranasally with the wildtype and recombinant viruses at the
indicated dose in 50 ml volumes, or mock inoculated with PBS.
Body weight was monitored continuously for 14 days. Infected
mice with more than 30% body loss were recorded as death cases.
To determine virus replication in the lungs of infected mice, mice
were inoculated intranasally with 10
4 TCID50 of the indicated
viruses and three per group were euthanized at 12, 24, 48, and
72 hpi. The right lobe of the lung was homogenized using an
ultra-turrax disperser (IKA, Konigswinter, Germany). Homoge-
nates were collected in 1 ml virus collection medium supplement-
ed with 0.2% BSA fraction V and 1% antibiotic-antimycotic.
Virus titers were determined by TCID50 assay.
Statistical analysis
All determinations were performed in triplicate and repeated
three times. Data are expressed as means 6 SEM. Statistical
significance was determined using non-parametric tests and the
GraphPad Prism 5 software package (GraphPad Software). A P
value,0.05 was deemed to indicate statistical significance.
Results
SNP analysis at 36 of PA and 357 of PB2
To determine whether the amino acid substitutions observed in
SC_PA-A36T and SC_PB2-H357N also exist in field strains, we
checked all public available sequences from GenBank. Up to Jan 30
th
2012, 5,875 and 5,633 sequences were filtered from initial 14,594 and
14,740PAand PB2 sequences, respectively,and used for polymorphic
analysis. Comprehensive analysis showed that residues at these two
positionswere highly conserved and 99.5% and 98.8% ofPAand PB2
gene contained the same residue as SC_WT, respectively. Amino acid
at position 357 in PB2 or 36 in PA displayed polymorphic, and the
substitutions similar to SC_PB2-H357N and SC_PA-A36T were rare
(Table 1). Of note, these mutations were detected in avian H5 and H7
subtype viruses which were currently recognized to pose potential
threat to human (Table 1, Table S1).
RNP complex with PA-A36T or PB2-H357N mutation
enhanced the polymerase activity at different
temperatures
In order to investigate whether the PA-A36T or PB2-H357N
mutations affect the enzymatic activity of RdRp, we analyzed the
PB2-H357N Increased the Virulence of 2009H1N1pdm
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(composed of PB2, PB1, PA, and NP) in 293T cells at different
temperatures using a mini-genome replication assay as described
previously [43]. The temperatures 33, 37, and 39uC were used to
approximate the conditions under which the influenza virus
polymerase would work in different hosts as previously described
[44]. As shown in Fig. 1, the polymerase activity of pH1N1
variants and WT displayed a temperature-dependent pattern and
was highly active at higher temperature, 37 or 39uC but much
lower at 33uC. A similar but less marked trend was also reported
by Bussey et al [45]. Moreover, remarkably higher activity was
observed in both PA-36T and PB2-357N than that of the WT at
both 37 and 39uC( p,0.001; n=3). Notably, the strongest RNP
activity of PA-A36T than PB2-357N and WT was detected at both
37 and 39uC, and was nearly 10-, and 20-fold increase as
compared with WT, respectively (p,0.001; n=3).
PA-A36T or PB2-H357N mutant replicated efficiently in
human, porcine and murine cells
Our ongoing study was to address the issues of the contribution
of adaptive mutations to viral replication and the effects of
temperature on the mutants during viral infection. Multi-cycle
growth assay of recombinant viruses containing PA-A36T or PB2-
H357N mutation was performed in human, porcine and murine
epithelial cell lines at 35 or 39uC at a MOI of 0.0001. As shown in
Figure 2, all the viruses replicated efficiently in the tested cells but
were relatively attenuated in murine cells as previously reported
elsewhere [38]. The virus titer progressively increased and peaked
around 10
5–10
7 TCID50/ml at 48 hpi. in the human lung
epithelia cell A549 and porcine kidney cell PK15. The mutation
of PA-A36T exhibited significantly elevated growth ability in both
A549 and PK15 cells with virus titers of more than 10-fold higher
than those of SC_WT at 24 hpi and the trend maintained
throughout the time course (Fig. 2A, B, C, D, p,0.001; n=3).
Significantly higher virus titer of SC_PB2-H357N mutant than
SC_WT was found in PK15 cells at 24 hpi. and the titer
maintained at a higher level at following time points although the
differences did not reach statistic significance (Fig. 2C, D). In LA-4
cells, statistical differences between them were found from 48 to
60 hpi at 39uC (Fig. 2F, p,0.05; n=3). In consistent with the
polymerase activity profile at different temperatures (Fig. 1), the
mutants displayed advantageous growth capability at a higher
temperature (Fig. 2).
Recombinant viruses containing PA-A36T or PB2-357N
mutation enhanced virulence in mice
To elucidate the contribution of the PB2-H357N and PA-A36T
mutations to virulence in mice, we used recombinant viruses to
determine the MLD50. In contrast to SC_PA-A36T and SC_WT
(10
5 and 10
5.5 TCID50 causing 50% mice death, respectively),
PB2-H357N has an MLD50 of 10
3.5 TCID50. Mice were
inoculated intranasally with 10
4 TCID50 of SC_WT, SC_PB2-
H357N, and SC_PA-A36T. Approximately 30% weight loss was
detected in SC_PB2-H357N-infected mice together with an 80%
mortality rate (Fig. 3A & B). In contrast, the SC_PA-A36T and
SC_WT viruses caused around 20% weight loss with no significant
difference (Fig. 3A). However, the former had a mortality rate of
20%, while all mice inoculated with SC_WT survived (Fig. 3B).
Table 1. Database search for SC_PB2-H357N or PA-A36T mutation in virus isolates from nature.
Viral gene Amino acid position Subtype Total no. sequences No. same as SC_WT No. same as SC_M No. different
PB2 357 H1 779 776(H) 2(N) 1(Y)
H3 738 734(H) 3(N) 1(Q)
H5 695 679(H) — 16(Y)
H9 286 279(H) — 7(Y)
Others* 3135 3133(H) 2(N; H4N2, H10N7) —
PA 36 H5 1816 1804(A) 12(T) 1(V)
H7 123 122(A) 1(T) —
H1 185 180(A) — 5(S)
Others* 3751 3947(A) 4(T; H4N6, H6N9, H9N2, H11N8) —
Polymorphisms of PA-36 and PB2-357 in influenza virus isolates were assessed and compared with our findings. The data shown are the number of sequenceso f
different influenza subtypes in the NCBI database, the number of sequences of identical same amino acid composition as SC_WT and SC_M, and the number of
sequences with a different amino acid at the same position (with the amino acids shown in parentheses). SC_M, SC_PB2-H357N/PA-A36T; Others*, subtypes which were
not listed above; —, not applicable.
doi:10.1371/journal.pone.0033383.t001
Figure 1. Viral RNA polymerase activity of SC_WT, SC_PA-A36T
and SC_PB2-H357N in 293T cells cultured at different temper-
atures. Luciferase-based minigenome reporter assays were used to
measure polymerase activity in 293T cells at 33, 37, or 39uC. Cells were
co-transfected with Gluc reporter plasmid and expression plasmids PB1
and NP, PA, and PB2 (WT or PA-A36T, PB2-H357N mutants) to generate
different viral RNPs. After culturing at 33, 37, or 39uC for 24 h, Gaussia
luciferase production was measured. Results are presented as mean 6
SEM and are representative of three determinations. **, p,0.001, as
determined by t-test.
doi:10.1371/journal.pone.0033383.g001
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more efficiently than SC_WT virus in vivo, we inoculated mice
with 10
4 TCID50 of each virus and analyzed virus titers in lung at
various time points post inoculation (Fig. 4). In line with viral
replication in LA-4 cells, titer of SC_PB2-H357N was significant
higher than that of WT at all the tested time points, and peaked
(.10
7 TCID50/ml) at 48 hpi (Fig. 4). Similar to viral replication in
A549 and PK15 cells , significantly higher titers of SC_PA-A36T
were detected at early stage, i.e., 24 hpi. (p,0.001; n=3), while
did not differ from that of SC_WT at any following time points.
Our study showed that the SC_PB2-H357N mutant displayed
marked replication activity in mice and caused severe infection
and high mortality.
Discussion
The polymerase complex of influenza A virus, known to
function in many aspects of viral replication and to interact with
host factors, therefore, play a critical role during viral adaptation
process. Unlike 1957 H2N2 and 1968 H3N2 pandemic viruses
caused by reassortants between avian and human influenza
viruses, 1918 H1N1 influenza virus derived its polymerase genes
Figure 2. Growth properties of recombinant viruses in human (A, B), porcine (C, D) and murine cells (E, F). Confluent monolayer of
A549, PK15 and LA-4 cell lines were inoculated with SC_WT, SC_PA-A36T or SC_PB2-H357N virus at MOI of 0.0001. Culture supernatants were
harvested at 12, 24, 48, 60, 72 and 96 hpi at 35(A, C, E)o r3 9 uC( B, D, F), respectively. Virus titers were determined by TCID50 assay using MDCK cells.
Results are presented as mean 6 SEM and are representative of three determinations. *, u, p,0.05, when comparing SC_PA-A36T and SC_PB2-H357N
with SC_WT respectively, as determined by a t-test of TCID50 values. **, uu, p,0.001, as determined by t-test.
doi:10.1371/journal.pone.0033383.g002
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finding that ten consensus residues observed in 1918 H1N1
polymerases and those from other mammalian viruses is indicative
of its human adaptation [46]. Several mutations in polymerase
genes associated with adaption of H5N1 virus in mammalian hosts
have been identified from human infection cases and mice model,
however, their introduction into pH1N1 did not exhibit altered
virulent phenotype in mice [15,29–32]. Therefore, the mutation
pattern of the polymerase complex required for viral adaptation
and virulence to a new host as well as underlying mechanisms
remains to be investigated. To decode the factors contributing to
adaptation and virulence of pH1N1 and to assess its potential risk
to human health, an experimental evolutionary study was
conducted and the polymerase mutations PA-A36T and PB2-
H357N, were observed in the mouse-adapted descendants of
pH1N1 virus-A/Sichuan/1/2009 (SC).
The variants with the detected mutations were characterized in
this study. Both mutations enhanced the polymerase activity
remarkably. Furthermore, the activity of WT and mutations
displayed a temperature-dependent pattern and highly active at
higher temperature. The mutations, particularly PA A36T,
exhibited the strongest up-regulation effect at 39uC than that of
either 33uCo r3 7 uC. Interestingly, the viruses containing the
mutations demonstrated similar temperature-dependent effects on
viral replication in mammalian cells from different species.
Although the mutants showed varied replication properties in
different cells, better growth of the mutants with PA-36T or PB2-
357N than WT in mammalian cells as well as increased RNP
activity are indicative of their mammalian adaptation. A
synergistic effect on polymerase activity rendered by dual PA-
36T and PB2-357N substitutions was observed (data not shown)
and the mutant containing PA-A36T and PB2-H357N accompa-
nied with HA-D222G was detected in our mice-adaptive
experiments. However, the variant with dual mutations, PA-36T
and PB2-357N, showed nearly identical virulence to that of WT in
mice model (data not shown). Of note, it was recently identified
that synergistic actions of HA D222G, K163E and PA F35L in
pH1N1 result in an enhanced pathogenicity in mice model [38].
Therefore, the virulence of influenza virus may depend on
numerous factors including cell tropism, viral infectivity or
replicate activity and so on. Our data together with other previous
reports, clearly showed that a high level of polymerase activity is
not the sole reason for increased viral replication or virulence
[14,15,30,32,47,48]. It is likely that a subtle functional optimum of
viral proteins during virus infection is required for high virulence.
As a part of hetrotrimeric RdRp, PA functions in diverse aspects
of the complex including endonuclease, protease and viral RNA
binding [49–52]. The position 36 in the N-terminal domain of PA,
which contains the endonuclease activities and was required for
cap snatching [53]. Thus, substitution of A36T in PA may affect
viral transcription and replication. Previous studies have showed
that the PA subunit is a virulence factor for H5N1 and pH1N1
influenza A virus [15,45,54,55]. Although the A36T in PA in our
study did not remarkably alter viral pathogenicity in mice, it
contributed significantly to RNP activity and viral replication in
mammalian cells, especially in PK15 cells. Since pig is the
hypothesized ‘mixing vessel’ for generating novel reassortants or
pandemic flu viruses, the superior growth properties of SC_PA-
A36T in PK15 cells implies a potential threat of the variants
carrying this mutation and required its monitoring in future work.
Figure 3. Pathogenicity of SC_WT, SC_PA-A36T, and SC_PB2-
H357N viruses in mice. Six-week-old female BALB/c mice (n=5/
group) were inoculated intranasally with 50 ml containing 10
4 TCID50 of
the recombinant viruses SC_WT, SC_PA-A36T, and SC_PB2-H357N, or
PBS (mock). (A) Morbidity was assessed by weight changes over a 14-
day period and is graphed as a percentage of the average weights on
the day of inoculation (day 0). The average body weight change of each
group is shown with error bars representing SEM (+/2). (B) Mortality
associated with infection with the recombinant viruses SC_WT, SC_PA-
A36T, and SC_PB2-H357N was also examined.
doi:10.1371/journal.pone.0033383.g003
Figure 4. Analysis of viral replication efficiency in the
respiratory tracts of mice. Six-week-old female BALB/c mice (n=3/
group/time-point) were inoculated intranasally with 50 ml containing
10
4 TCID50 of SC_WT, SC_PA-A36T, and SC_PB2-H357N. Animals were
euthanized at 12, 24, 48 and 72 hpi. The right lung of each animal was
homogenized in PBS (1 ml) and then centrifuged. Viral titers in the
supernatant from lung homogenates were determined by TCID50 assay.
Results are presented as mean 6 SEM and are representative of three
determinations. *, p,0.05 and **, p,0.001, as determined by t-test.
doi:10.1371/journal.pone.0033383.g004
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PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e33383Residues 242–252(N-site), 318–483(C-site) and 533–577 are
thought to be the cap-binding domain on PB2. Position 357 is
located at the C-terminal of strand b4 which was mapped to
positions 318 to 483 and was involved in viral transcription via
snatching the cap of host mRNA. H357A mutation could decrease
PB2’s cap binding activity and thus reduce mRNA transcription
while H357W showed an enhanced binding to m
7GTP [56].
Theoretically, asparagines (N) at position 357 of PB2 observed
here might attenuate the binding to m7GTP as compared with W
or Y. Nonetheless, enhanced polymerase activity and higher
virulence in mice were detected.
Systematic analyzing PA and PB2 sequences from all available
data of GenBank showed high conservation of the both residues in
field isolates and less than 1% viruses possessed mice adaptive
mutations. Such mutations exclusively presented in avian viruses
including H5 and H7 subtypes. Although whether the mutation
pattern for pH1N1, observed here, represents a preferred viral
strategy to gain virulence is still unclear, careful monitoring these
virulence enhancing mutations is critical important for pandemic
preparedness and response due to increasing interspecies trans-
mission events of pH1N1 virus into other hosts have been
documented [57–61]. In summary, our results show that the
amino acid 36T in PA and 357N in PB2 contribute to polymerase
activity and viral replication of pH1N1 in mammalian cells. The
amino acid 357N in PB2 also plays a role in viral pathogencity in
mice model.
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